EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 3.0

Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study

Kimberly Daniels iD, Stephan Lanes, Arlene Tave, Michael F Pollack iD, David M Mannino, Gerard Criner, Amanda Neikirk, Kirsty Rhodes, Norbert Feigler, Clementine Nordon

International Journal of Chronic Obstructive Pulmonary Disease · 2024-01 · Volume 19 · 225-241

DOI: 10.2147/copd.s438893 ↗

At a glance

Journal article in International Journal of Chronic Obstructive Pulmonary Disease, 2024-01. Written by Kimberly Daniels and 9 co-authors. Institution: Safety and Epidemiology, Carelon Research, Wilmington, DE, USA. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Cardiovascular Diseases. Cited 52 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC 3.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

This study estimated the magnitude and duration of risk of cardiovascular events and mortality following acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and whether risks varied by number and severity of exacerbation in a commercially insured population in the United States.

Methods

This was a retrospective cohort study of newly diagnosed COPD patients ≥40 years old in the Healthcare Integrated Research Database from 2012 to 2019. Patients experiencing exacerbations comprised the "exacerbation cohort". Moderate exacerbations were outpatient visits with contemporaneous antibiotic or glucocorticoid administration; severe exacerbations were emergency department visits or hospitalizations for AECOPD. Follow-up started on the exacerbation date. Distribution of time between diagnosis and first exacerbation was used to assign index dates to the "unexposed" cohort. Cox proportional hazards models estimated risks of a cardiovascular event or death following an exacerbation adjusted for medical and prescription history and stratified by follow-up time, type of cardiovascular event, exacerbation severity, and rank of exacerbation (first, second, or third).

Results

Among 435,925 patients, 170,236 experienced ≥1 exacerbation. Risk of death was increased for 2 years following an exacerbation and was highest during the first 30 days (any exacerbation hazard ratio (HR)=1.79, 95% CI=1.58-2.04; moderate HR=1.22, 95% CI=1.04-1.43; severe HR=5.09, 95% CI=4.30-6.03). Risks of cardiovascular events were increased for 1 year following an AECOPD and highest in the first 30-days (any exacerbation HR=1.34, 95% CI=1.23-1.46; moderate HR=1.23 (95% CI 1.12-1.35); severe HR=1.93 (95% CI=1.67-2.22)). Each subsequent AECOPD was associated with incrementally higher rates of both death and cardiovascular events.

Conclusion

Risk of death and cardiovascular events was greatest in the first 30 days and rose with subsequent exacerbations. Risks were elevated for 1-2 years following moderate and severe exacerbations, highlighting a sustained increased cardiopulmonary risk associated with exacerbations.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveCardiovascular DiseasesHumansAdultRetrospective StudiesAnti-Bacterial AgentsCluster Analysis

Author keywords

COPDcardiac eventscardiopulmonaryepidemiologylongitudinal studies

Substances

Anti-Bacterial Agents

Authors and institutions

  • Safety and Epidemiology, Carelon Research, Wilmington, DE, USA.
  • Global Medical Affairs, AstraZeneca, Wilmington, DE, USA.
  • College of Medicine, University of Kentucky, Lexington, KY, USA.
  • Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.

ORCID profiles: Kimberly Daniels, Michael F Pollack

Cite

APA

Daniels, K., Lanes, S., Tave, A., Pollack, M. F., Mannino, D. M., Criner, G., Neikirk, A., Rhodes, K., Feigler, N., & Nordon, C. (2024). Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 225-241. https://doi.org/10.2147/copd.s438893

Vancouver

Daniels K, Lanes S, Tave A, Pollack MF, Mannino DM, Criner G, et al. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study. International Journal of Chronic Obstructive Pulmonary Disease. 2024;Volume 19:225-241. doi:10.2147/copd.s438893

BibTeX
@article{Daniels2024,
  author = {Daniels, Kimberly and Lanes, Stephan and Tave, Arlene and Pollack, Michael F and Mannino, David M and Criner, Gerard and Neikirk, Amanda and Rhodes, Kirsty and Feigler, Norbert and Nordon, Clementine},
  title = {Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  volume = {Volume 19},
  pages = {225--241},
  doi = {10.2147/copd.s438893}
}
Start for free →